Home > PS Ratio > JUBILANT PHARMOVA

JUBILANT PHARMOVA
PS (Price/Sales) Ratio

The Current P/S Ratio of JUBILANT PHARMOVA is 2.09.

Share Price ₹928.8Apr 04,2025
Market Cap ₹14,795.0 Cr
Sales-TTM₹7,064.3 CrTTM-Consolidated Results
Price/Sales2.09xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for JUBILANT PHARMOVA
Please provide your vote to see the results
JUBILANT PHARMOVA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of JUBILANT PHARMOVA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of JUBILANT PHARMOVA is calculated as :

Current Market Cap [ ₹14,795.0 Cr] as on Apr 04,2025

(/) Sales [ ₹7,064.3 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.09x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for JUBILANT PHARMOVA , the investors are currently willing to pay '2.09 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of JUBILANT PHARMOVA !

The chart below summarizes the trend in P/S Ratio of JUBILANT PHARMOVA over the last five years.

Historical PS (Price/Sales) ratio chart of JUBILANT PHARMOVA


PS Ratio Performance Analysis for JUBILANT PHARMOVA

- JUBILANT PHARMOVA 's latest p/e ratio is 2.09x.

- JUBILANT PHARMOVA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.10x.

- JUBILANT PHARMOVA 's operated at median p/e ratio of 1.01x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, JUBILANT PHARMOVA 's p/e ratio peaked in Mar2021 at 1.78x.

- JUBILANT PHARMOVA 's p/e ratio hit its five-year low in Mar2020 of 0.66x.


How does JUBILANT PHARMOVA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
JUBILANT PHARMOVA 7,064.32.0914,795.0
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.95410,142.0
DIVIS LABORATORIES LTD9,078.016.06145,762.0
CIPLA LTD26,981.24.24114,322.0
TORRENT PHARMACEUTICALS LTD11,302.09.84111,171.0
DR REDDYS LABORATORIES LTD31,229.32.9792,603.7
MANKIND PHARMA LTD11,641.08.68101,098.0
ZYDUS LIFESCIENCES LTD22,247.43.9287,205.3
LUPIN LTD22,001.64.0989,993.5
AUROBINDO PHARMA LTD30,921.82.0864,167.0
ABBOTT INDIA LTD6,243.29.8961,727.3

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JUBILANT PHARMOVA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.08x
Max industry PS 16.06x
Median industry PS 4.24x
Average industry PS 6.53x



You may also like the below Video Courses